Larouze B, Schaffar-Deshayes L, Blesonski S, Gaudebout C, Afoutou J M, Couillin P, Da Graca Porto M, Diakhate L, Frelut M L, Jeddi M
Cancer Res. 1985 Sep;45(9 Suppl):4630s-4632s.
Using a radioimmunoassay to detect HTLV-I protein antibodies of molecular weight 24,000, we screened populations from Algeria (140 subjects), Tunisia (442), Mali (69), Senegal (415), Uganda (135), the Central African Republic (77), the Congo (360), and Madagascar (193). Only four subjects were positive (1 from Senegal, 1 from Uganda, 2 from the Congo). This is a much lower figure than that found by others in Africa by the enzyme-linked immunosorbent assay technique. In addition, 319 Portuguese blood donors (46 of whom have lived in Angola or Mozambique) were screened using the same radioimmunoassay. All were negative.
我们使用放射免疫分析法检测分子量为24,000的人类嗜T淋巴细胞病毒I型(HTLV-I)蛋白抗体,对来自阿尔及利亚(140名受试者)、突尼斯(442名)、马里(69名)、塞内加尔(415名)、乌干达(135名)、中非共和国(77名)、刚果(360名)和马达加斯加(193名)的人群进行了筛查。只有4名受试者呈阳性(1名来自塞内加尔,1名来自乌干达,2名来自刚果)。这一数字远低于其他研究人员在非洲采用酶联免疫吸附测定技术所得到的结果。此外,我们使用相同的放射免疫分析法对319名葡萄牙献血者(其中46人曾在安哥拉或莫桑比克居住过)进行了筛查。所有人均为阴性。